Abstract Background/Aims: Atherosclerosis is a chronic inflammatory condition associated with a variety of vascular diseases. Previous studies showed that both miR-29a and oxidized low density lipoprotein (ox-LDL) were vital in the development of atherosclerosis. However, the relationship between miR-29a and ox-LDL remains unknown. This study was designed to investigate the association of miR-29a and ox-LDL and to test whether circulating miR-29a and ox-LDL levels could predict atherosclerosis. Methods: In 170 participants, plasma levels of miR-29a were assessed by quantitative real-time polymerase chain reaction (qRT-PCR) while plasma ox-LDL levels were determined using enzyme-linked immunosorbent assay (ELISA) kits. The relationship between miR-29a level and ox-LDL and carotid intima-media thickness (cIMT) was assessed using the Spearman correlation coefficient and multiple liner regression. Results: Compared with the normal cIMT group, the increased cIMT group had higher levels of ox-LDL (0.47 ± 0.08 vs 0.29 ± 0.06 ng/ml, p = 0.003) and miR-29a (32.93 ± 4.26 vs 26.37 ± 1.04, p < 0.001). A positive correlation was found between ox-LDL and miR-29a (r = 0.695, p < 0.001), and both the ox-LDL (r = 0.857, p < 0.001) and the miR-29a (r = 0.753, p < 0.001) were positively related to cIMT. Furthermore, multiple liner regression indicated that a significant correlation between ox-LDL and cIMT (β = 0.768, p < 0.001), as well as between miR-29a and cIMT (β = 0.686, p <0.001). The combination of miR-29a and ox-LDL (AUC = 0.926, p < 0.001) offered a better predictive value for atherosclerosis than either miR-29a (AUC = 0.759, p < 0.001) or ox-LDL (AUC = 0.762, p < 0.001) alone. Conclusion: Increased miR-29a and ox-LDL levels were associated with an early stage of atherosclerosis, and the combination of miR-29a and ox-LDL offered better predictive values for atherosclerosis than either alone.
Introduction
Atherosclerosis is a chronic inflammatory condition associated with a variety of vascular diseases including coronary heart disease, ischemic stroke and peripheral artery disease [1, 2] . Carotid intima-media thickness (cIMT) measurement is routinely used to assess subclinical atherosclerosis or atherosclerosis [3] . The cIMT has been shown to predict cardiovascular events in multiple large studies and be recommended for cardiovascular risk assessment in asymptomatic adults at intermediate risk of cardiovascular disease [4, 5] . Recently, more and more novel biomarkers were found to play an important role in predicting cardiovascular outcomes.
MicroRNAs (miRs) are noncoding RNAs regulating gene expression by recognizing target messenger RNA (mRNA) [6] . They are involved in almost every aspect of cellular process and miRs dys-regulation was associated with many cardiovascular diseases [7] . Also, miRs, as small non-coding RNAs which are key post-transcriptional regulators of gene expression in all eukaryotic cells, have been found to modulate the function of endothelial cells (ECs) [8] , endothelial progenitor cells (EPCs) [9] ,smooth muscle cells (SMCs) and peripheral blood mononuclear cells (PBMCs) [10] through controlling the expressions of chemokines or enhancing inflammatory response in atherosclerosis [11] . Oxidized low-density lipoprotein (ox-LDL) is considered as an early marker of oxidative stress and lipid peroxidation [12] . A lot of researches have demonstrated that oxidative stress contributes to the pathogenesis of atherosclerotic cardiovascular diseases [13] . In addition, ox-LDL plays important roles in monocytes activation and infiltration and SMCs proliferation [14] . The ox-LDL and miR-29a have been reported to play a vital role in the development of atherosclerosis by modulating ECs and SMCs [15, 16] . However, few data were found on the association of atherosclerosis with ox-LDL, as well as with miR-29a. And the predictive values of ox-LDL and miR-29a for atherosclerosis remained less well studied. Therefore, this study was designed to analyze the differences of miR-29a and ox-LDL levels between the normal controls and those with increased cIMT and discuss the potential roles of miR-29a and ox-LDL as predictors for atherosclerosis.
Materials and ethods M

Study Population
This was a cross-sectional study and all the participants were from Guangdong General Hospital, Guangdong, China. Patients with asymptomatic atherosclerosis were included. Patients with a history of coronary heart disease, cerebrovascular disease, diabetes mellitus, heavy smokers, tumor and relevant medications (lipid-lowering, antiplatelet or antihypertensive drugs) were excluded. All of the participants underwent physical examination and office blood pressure measurements. The carotid arteries were examined using a standardized protocol. The cIMT of the common carotid artery was measured by ATL HDI 3000 ultrasound system (Advanced Technology Laboratories, Bothell, WA) equipped with a 5 MHz linear array transducer as previously described [17, 18] . The value of cIMT < 0.9mm was defined as normal while cIMT ≥ 0.9mm was defined as increased cIMT. A Subclinical atherosclerosis was defined as cIMT ≥ 0.9 mm but < 1.2mm and atherosclerosis was defined as cIMT ≥ 1.2 mm, according to the 2007 Guidelines for the management of arterial hypertension released by the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [19] . The higher value between left and right cIMT was used for study analyses. A trained sonographer with registered diagnostic medical sonography certification performed the measurements. The study was approved by the Medical Ethics Committee of Guangdong General Hospital. Written informed consent was obtained from each patient prior to participation. The study was conducted in accordance with the Declaration of Helsinki.
Sample Collection
All samples were collected prior to any treatment from each patient and healthy volunteer in the morning after 12 -14h fasting. Plasma was extracted by centrifuging blood sample at 3000 rpm for 10 min at room temperature; plasmas were collected and divided into 2 aliquots, then frozen as separate aliquots at −80°C for storage before used for analysis. Fasting blood glucose, serum lipid profiles, routine laboratory tests and renal functions were measured by routine methods.
The detection of ox-LDL and miR-29a
Total RNA containing small RNAs was extracted from plasma using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and purified with mirVana miR Isolation Kit (Ambion, Austin, TX, USA) according to the manufacture's protocols [20, 21] . We evaluated plasma miRs using the S-Poly (T) RT-qPCR method as previously described [22] , using miR-54 as a control [23] . The comparative cycle threshold (Ct) (ΔCt) was used to calculate the relative level of miRs. Mean Ct values and deviations between the duplicates were calculated for all samples. ΔCt = Ct (miR)-Ct (miR-54). Plasma ox-LDL levels were determined using enzymelinked immunosorbent assay (ELISA) kits (Calbiochem, San Diego, USA) according to the manufacturer's instructions [24] .
Statistical analysis
We found a sample size of n=32 per group is required to provide 90% power to detect a difference in the mean relative expression levels with a significance of 0.001 (2-sidedα).All the continuous variables were expressed as mean ± standard deviation. The Mann-Whitney U test or Student t test was used for continuous variables between patients and controls. The one way ANOVA test was used to show differences between groups for continuous numeric parameters with normal distribution, and Tukey's test was used for posthoc analyses. Correlations between continuous variables were assessed using the Spearman correlation coefficient. Multiple linear regression analysis was used to assess relationships between miR-29a levels and cIMT or ox-LDL, and age, body mass index, systolic blood pressure and low density lipoprotein cholesterol were adjusted. Statistical significance was defined as two-sided p < 0.05. The predictive value of being diagnosed with atherosclerosis was evaluated using the receiver operating characteristic (ROC). Area under the ROC curve (AUC) was used as an accuracy index for evaluating the diagnostic performance of the selected miR-29a and ox-LDL. Statistical analyses were performed using the statistical Package for the Social Sciences (SPSS) version 17.0 software (SPSS Inc, Chicago, IL, USA) and GraphPad Prism 5(GraphPad Software, La Jolla, CA, USA).
Results
Clinical characteristics, plasma ox-LDL concentration and miR-29a levels.
Demographic, clinic and laboratory characteristics of increased cIMT group and normal cIMT group are shown in Table 1 . There were significant differences between these two groups in systolic blood pressure, C-reactive protein, plasma ox-LDL concentration and miR29a levels. We observed higher miR-29a levels (32.93 ± 4.26 vs 26.37 ± 1.04; p < 0.001) in increased cIMT group compared with normal cIMT group (Fig. 1A) , and as well as plasma ox-LDL concentration (0.47 ± 0.08 vs 0.29 ± 0.06; p = 0.003) was also higher in increased cIMT group (Fig. 1B) . Subgroup analysis showed that there were significant differences in ox-LDL (0.29 ± 0.06 vs 0.41 ± 0.05 vs 0.54 ± 0.06 ng/ml, p <0.001) and miR-29a (26.38 ± 1.04 vs 30.83 ± 3.51 vs 34.79 ± 4.02, p < 0.001) among normal group, subclinical atherosclerosis group and atherosclerosis group (Table 2, Fig. 2A and 2B ).
The correlation of miR-29a and ox-LDL with cIMT.
As shown in Table 3 , we found the level of ox-LDL was positively related with cIMT (r = 0.857, p < 0.001) and miR-29a (r = 0.695, p < 0.001). The level of miR-29a was also positively related with cIMT (r = 0.753, p < 0.001). Multivariate linear regression analysis showed that ox-LDL (β = 0.768, 95 % CI 0.535-0.891; p < 0.001) and miR-29a (β = 0.686, 95 % CI 0.560-0.792; p < 0.001) were still associated with cIMT after adjusted for age, body mass index, systolic blood pressure, low density lipoprotein cholesterol and C-reactive protein (Table 4) . Table 1 . Demographic, clinic and laboratory characteristics between groups. HDL-C, high-density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; GFR, glomerular filtration rate; CRP, C-reactive protein; DBP ,diastolic blood pressure; SBP, systolic blood pressure. Data are presented as the mean ± standard deviation Table 2 . Demographic, clinic and laboratory characteristics among groups. HDL-C, high-density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; ox-LDL, oxidized low density lipoprotein; GFR, glomerular filtration rate; CRP, C-reactive protein; DBP ,diastolic blood pressure; SBP, systolic blood pressure; AS, atherosclerosis. Data are presented as the mean ± standard deviation ox-LDLlevel in in normal cIMTgroup, subclinical atherosclerosis group and atherosclerosis group.cIMT, carotid intima-media thickness.Data are presented asmeans±standard deviation.p-values from the one way ANO-VA arepresented. Table 3 . Relationship of miR-29a expression levels with ox-LDL and cIMT. cIMT; carotid intima-media thickness, ox-LDL; oxidized low density lipoprotein. The Pearson correlation coefficient was used for statistical analysis Table 4 . Multivariate linear regression analysis the relationship of miR29a expression levels and ox-LDL with cIMT. cIMT; carotid intima-media thickness, ox-LDL; oxidized low density lipoprotein. Multivariate linear regressions analysis were used for statistical analysis, and age, body mass index, systolic blood pressure and low density lipoprotein cholesterol were adjusted 
Predictive value of miR29a and ox-LDL for atherosclerosis.
In addition, we performed a ROC analysis to determine the predictive values of miR-29a and ox-LDL for atherosclerosis. The AUC of the miR-29a was 0.759 (95% CI 0.673-0.845; p < 0.001), and the AUC of the ox-LDL was 0.762 (95% CI 0.682-0.842; p < 0.001). Importantly when the miR-29a combined ox-LDL to form a composite panel, the AUC of the panel was 0.926 (95 % CI 0.887-0.964; p < 0.001). This indicated that the diagnostic performance of the miR-29a and ox-LDL panel was superior to miR-29a or ox-LDL alone (Fig. 3) .
Discussion
According to our study, an upward trend was found in miR-29a and ox-LDL levels that it ran from the healthy controls (being the lowest) through subclinical AS group to AS group. Our data also showed that miR-29a levels were positively associated with ox-LDL and cIMT. In addition ox-LDL levels were also positively related with cIMT. Furthermore, our study showed both miR-29a and ox-LDL had a very good predictive value for atherosclerosis. The most important and interesting discovery of our study was that the AUC of the panel was superior to that of miR-29a or ox-LDL alone when it was composed of miR-29a and ox-LDL.
Both miR-29a and ox-LDL serve as a vital role in the development of atherosclerosis. MiR-29a is a typical multifunctional miRNA which is involved in regulating the epithelialmesenchymal transition, cellular differentiation, extracellular matrix remodeling and angiogenesis [25, 26] . A previous study revealed that miR-29a regulated not just transcript abundance, but also protein levels of extracellular matrix components, such as collagen I, collagen III, and collagen VI in quiescent cells [27] . Further study showed that miR-29a adjusted collagen synthesis dependent on transforming growth factor-betas (TGF-ß) signaling pathway [28] . Multiple researches demonstrated TGF-ß played an important role in atherosclerosis [29, 30] . Previous studies have shown that miR-29 up-regulation was associated with vascular abnormality [31] and miR-29 was involved in vascular smooth muscle cell migration and proliferation by mediating an epigenetic mechanism, which is related to atherosclerosis [32] .Our results were also showed miR-29 levels were higher in atherosclerosis patient than normal controls, which was similar to previous research results. In addition, as well-known that inflammatory reaction is an important process of atherosclerosis. Studies suggested that a dys-regulation of growth factors, inflammatory cytokines, chemokines play a role in atherosclerosis [33] . Yang et al illuminated that vascular endothelial growth factor-A was a direct target of miR-29a, and miR-29a was strongly related to endogenous vascular endothelial growth factor-A [26] .
Interestingly, in this study, we identified a positive correlation between levels of miR29a and ox-LDL, and both the levels of miR-29a and ox-LDL were also positively associated with cIMT. The ox-LDL, a typical biomarker for oxidative stress in these pathological conditions, which contributes to the enhanced oxidative stress in macrophages and some other cells through promoting and augmenting the generation of reactive oxygen species [34, 35] . Recent studies indicated that ox-LDL stimulated plasminogen activator inhibitor-1 expression in human mesangial cells mediated by the transforming growth factor-β (TGF-β)/Smad signaling pathway which was related to atherosclerosis [36] . Furthermore, study clarified that increased expression of interleukin-10 might help to attenuate the risk of atherosclerosis mediated by pro-inflammatory signal through the interaction of oxLDL with its cognate receptor lipoprotein receptor-1 on macrophages [37] . Of course, both ox-LDL and miR-29a are a major component of hyperlipidemia and contributes to atherosclerosis [38] . Our results showed that ox-LDL was positive with miR-29a, suggesting that excessive expression of miR-29a and ox-LDL might aggravate atherosclerosis. Although we found that there was a correlation between miR-29a and ox-LDL, the underlying mechanisms responsible for the association of miR-29a and ox-LDL with cIMT were not elucidated. The potential role of miR-29a and ox-LDL in atherosclerosis needs to be further determined by basic research.
Limitations
Of course, several potential limitations of this study should be taken into consideration. Firstly, this was a single-center study with a small sample size. Multicenter studies with larger sample sizes are needed. Secondly, as a cross-sectional study, it suggests the hypotheses while fails to describe the relationship between the putative cause and effect. Thirdly, the mechanisms of miR-29a in regulating atherosclerosis were still not entirely clear in human. The potential role of miR-29a and ox-LDL in atherosclerosis needs to be further determined by basic research. Finally, the ultrasonic outcome is subject to the operator's experience and level of technical skills, so diagnostic accuracy will be greatly limited. Therefore, some new methods should be explored to detect and evaluate atherosclerosis.
Conclusions
In conclusion, our findings suggested that plasma levels of miR-29a and ox-LDL are higher in those with subclinical atherosclerosis or atherosclerosis when compared with healthy populations. Both miR-29a and ox-LDL levels are positively related to cIMT. Also, both miR-29a and ox-LDL show a good predictive value for atherosclerosis. Furthermore, our study demonstrates a higher predicting power for atherosclerosis when miR-29a and ox-LDL are used together. Therefore, miR-29a and ox-LDL may be potential biomarkers for atherosclerosis.
